{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:15:37Z","timestamp":1771604137214,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11904-017-0367-7","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T04:50:10Z","timestamp":1508907010000},"page":"201-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Preexposure Prophylaxis of HIV Infection: the Role of Clinical Practices in Ending the HIV Epidemic"],"prefix":"10.1007","volume":"14","author":[{"given":"Iryna B.","family":"Zablotska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine C.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"issue":"12","key":"367_CR1","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973\u201383.","journal-title":"AIDS"},{"issue":"1","key":"367_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/COH.0000000000000220","volume":"11","author":"JE Haberer","year":"2016","unstructured":"Haberer JE. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice. Curr Opin HIV AIDS. 2016;11(1):10\u20137.","journal-title":"Curr Opin HIV AIDS"},{"key":"367_CR3","unstructured":"UNAIDS - The Joint United Nations Programme on HIV\/AIDS. 2016 Prevention gap report. UNAIDS communications. Available online at http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2016-prevention-gap-report_en.pdf . Last accesssed: 15 June 2017."},{"key":"367_CR4","unstructured":"US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States \u2013 2014. A clinical practice guideline. Available online http:\/\/www.cdc.gov\/hiv\/pdf\/guidelines\/PrEPguidelines2014.pdf . Last accessed on 2 March 2015."},{"key":"367_CR5","unstructured":"ASHM. Australian natinal PrEP guidelines - 2015. Available online http:\/\/arv.ashm.org.au\/arv-guidelines\/prep-resources-for-clinicians . Last accessed on 2 March 2015."},{"key":"367_CR6","unstructured":"European AIDS clinical society. Guidelines version 8.0 October 2015. Available online at: http:\/\/www.eacsociety.org\/files\/2015_eacsguidelines_8_0-english_rev-20160124.pdf Last accessed 10 Janaury 2016."},{"issue":"2","key":"367_CR7","first-page":"40","volume":"13","author":"The Concensus Committee SAHCS","year":"2012","unstructured":"The Concensus Committee SAHCS. Southern African guidelines for the safe use of pre-exposure prophylaxis in men who have sex with men who are at risk for HIV infection. SAJHIVMED. 2012;13(2):40\u201355.","journal-title":"SAJHIVMED"},{"key":"367_CR8","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. September 2015. NLM classification: WHO\/WC 503.2. Available online at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/186275\/1\/9789241509565_eng.pdf . Last accessed on 29 July 2016."},{"key":"367_CR9","unstructured":"United Nations General Assembly. Political declaration on HIV and AIDS: on the fast-track to accelerate the fight against HIV and to end the AIDS epidemic by 2030. 08 June 2016. Available online at: http:\/\/www.unaids.org\/en\/resources\/documents\/2016\/2016-political-declaration-HIV-AIDS . Last accessed on 28 July 2016."},{"key":"367_CR10","unstructured":"UNAIDS - The Joint United Nations Programme on HIV\/AIDS. 2016 Update on pre-exposure prophylaxis (PrEP). 31 October 2016. Available online at http:\/\/www.unaids.org\/en\/resources\/presscentre\/featurestories\/2016\/october\/20161031_PrEP . Last accesssed: 15 June 2017."},{"key":"367_CR11","doi-asserted-by":"crossref","unstructured":"Zablotska IB. Likely impact of pre-exposure prophylaxis on HIV epidemics among men who have sex with men. Sex Health. 2016.","DOI":"10.1071\/SH16153"},{"issue":"2 Suppl","key":"367_CR12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2149\/tmh.2014-S13","volume":"42","author":"J Tanuma","year":"2014","unstructured":"Tanuma J. Global efforts against HIV epidemic and HIV vaccine development. Tropical medicine and health. 2014;42(2 Suppl):91\u20132.","journal-title":"Tropical medicine and health"},{"key":"367_CR13","unstructured":"Mera R, McCallister S, Palmer B, Mayer G, Magnuson D, Rawlings K. Truvada (TVD) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States (2013\u20132015). 21st International AIDS Conference, Durban, abstract TUAX0105LB. 2016."},{"key":"367_CR14","unstructured":"Molina J-M. PrEP rollout in France. 21st International AIDS Conference, Durban, symposium WEWS0804. 2016."},{"key":"367_CR15","unstructured":"Zablotska I. Expanded implementation of PrEP across Australia. International AIDS Conference in Durban, 17\u201322 July 2016. Oral abstract WEWS0805. Available at: http:\/\/programme.aids2016.org\/ Last accessed on 2 July 2016."},{"key":"367_CR16","unstructured":"NSW Government. Ministry of Health. NSW HIV Strategy 2016\u20132020 January\u2013March 2017 Data Report. Availalbe online at http:\/\/www.health.nsw.gov.au\/endinghiv\/Documents\/q1-2017-nsw-hiv-data-report.pdf . Last accessed on 20 June 2017."},{"key":"367_CR17","unstructured":"Hennessy J (MP, MInister for Health). Victoria State Government. Victoria funds PrEP expansion after federal government refuses again. Media release. Friday, 24 march, 2017. Availabe online at https:\/\/284532a540b00726ab7e-ff7c063c60e1f1cafc9413f00ac5293c.ssl.cf4.rackcdn.com\/wp-content\/uploads\/2017\/03\/170324-Victoria-Funds-PrEP-Expansion-After-Federal-Government-Refuses-Again.pdf . Last accessed on 20 June 2017."},{"key":"367_CR18","unstructured":"Center For Health And Gender Equity (CHANGE). The U.S. Dreams partnership: breaking barriers to HIV prevention for adolescent girls and young women. Report. November 30, 2016. Available online at http:\/\/www.genderhealth.org\/files\/uploads\/change\/publications\/CHANGE_Dreams_Report_Updated.pdf . Last accessed 5 August 2017."},{"issue":"7(Suppl 6)","key":"367_CR19","doi-asserted-by":"crossref","first-page":"21119","DOI":"10.7448\/IAS.19.7.21119","volume":"19","author":"I Zablotska","year":"2016","unstructured":"Zablotska I, Grulich AE, Phanuphak N, et al. PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers. J Int AIDS Soc. 2016;19(7(Suppl 6)):21119.","journal-title":"J Int AIDS Soc"},{"issue":"7(Suppl 6)","key":"367_CR20","doi-asserted-by":"crossref","first-page":"21113","DOI":"10.7448\/IAS.19.7.21113","volume":"19","author":"G Ravasi","year":"2016","unstructured":"Ravasi G, Grinsztejn B, Baruch R, et al. Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America. J Int AIDS Soc. 2016;19(7(Suppl 6)):21113.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"367_CR21","doi-asserted-by":"crossref","first-page":"21348","DOI":"10.7448\/IAS.19.1.21348","volume":"19","author":"R Baggaley","year":"2016","unstructured":"Baggaley R, Dalal S, Johnson C, et al. Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV response. J Int AIDS Soc. 2016;19(1):21348.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"367_CR22","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1371\/journal.pmed.0030332","volume":"3","author":"M Westerhaus","year":"2006","unstructured":"Westerhaus M, Castro A. How do intellectual property law and international trade agreements affect access to antiretroviral therapy? PLoS Med. 2006;3(8):e332.","journal-title":"PLoS Med"},{"key":"367_CR23","doi-asserted-by":"crossref","unstructured":"Broekhuis J, Scarsi KK, Sayles H, Klepser D, Havens J, Swindells S, Bares SH. Midwest pharmacists\u2019 knowledge of & willingness to provide preexposure prophylaxis. Conference on Retroviruses and Opportunistic Infections (CROI), February 13\u201316, 2017; Seattle, Washington. Abstract #963.","DOI":"10.1371\/journal.pone.0207372"},{"key":"367_CR24","unstructured":"Tung E, Thomas A, Eichner A, Shalit P. Feasibility of a pharmacist-run HIV PrEP clinic in a community pharmacy setting. Conference on Retroviruses and Opportunistic Infections (CROI), February 13\u201316, 2017; Seattle, Washington. Abstract #961."},{"key":"367_CR25","unstructured":"Collins BC, Bronson HW, Martin EG. Assessing the efficacy and feasibility of a retail pharmacy-based HIV testing program. Conference on Retroviruses and Opportunistic Infections (CROI), February 13\u201316, 2017; Seattle, Washington. Abstract #962."},{"issue":"9","key":"367_CR26","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/09540121.2016.1153595","volume":"28","author":"LM Adams","year":"2016","unstructured":"Adams LM, Balderson BH. HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. AIDS Care. 2016;28(9):1154\u20138.","journal-title":"AIDS Care"},{"issue":"1","key":"367_CR27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11606-016-3903-z","volume":"32","author":"OJ Blackstock","year":"2017","unstructured":"Blackstock OJ, Moore BA, Berkenblit GV, et al. A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians. J Gen Intern Med. 2017;32(1):62\u201370.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"367_CR28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s10461-015-0996-z","volume":"19","author":"J Blumenthal","year":"2015","unstructured":"Blumenthal J, Jain S, Krakower D, et al. Knowledge is power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav. 2015;19(5):802\u201310.","journal-title":"AIDS Behav"},{"issue":"2","key":"367_CR29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10461-013-0675-x","volume":"18","author":"SK Calabrese","year":"2014","unstructured":"Calabrese SK, Earnshaw VA, Underhill K, Hansen NB, Dovidio JF. The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access. AIDS Behav. 2014;18(2):226\u201340.","journal-title":"AIDS Behav"},{"issue":"5","key":"367_CR30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/QAI.0000000000000780","volume":"70","author":"AD Castel","year":"2015","unstructured":"Castel AD, Feaster DJ, Tang W, et al. Understanding HIV care provider attitudes regarding intentions to prescribe PrEP. J Acquir Immune Defic Syndr. 2015;70(5):520\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"367_CR31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/hiv.12285","volume":"17","author":"M Desai","year":"2016","unstructured":"Desai M, Gafos M, Dolling D, McCormack S, Nardone A, Study P. Healthcare providers' knowledge of, attitudes to and practice of pre-exposure prophylaxis for HIV infection. HIV medicine. 2016;17(2):133\u201342.","journal-title":"HIV medicine"},{"issue":"5","key":"367_CR32","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/cid\/cit796","volume":"58","author":"MY Karris","year":"2014","unstructured":"Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM. Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clin Infect Dis. 2014;58(5):704\u201312.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"367_CR33","doi-asserted-by":"crossref","first-page":"e0132398","DOI":"10.1371\/journal.pone.0132398","volume":"10","author":"DS Krakower","year":"2015","unstructured":"Krakower DS, Oldenburg CE, Mitty JA, et al. Knowledge, beliefs and practices regarding antiretroviral medications for HIV prevention: results from a survey of healthcare providers in New England. PLoS One. 2015;10(7):e0132398.","journal-title":"PLoS One"},{"issue":"46","key":"367_CR34","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.15585\/mmwr.mm6446a5","volume":"64","author":"FN Laufer","year":"2015","unstructured":"Laufer FN, O'Connell DA, Feldman I, Zucker HA. Vital signs: increased Medicaid prescriptions for Preexposure prophylaxis against HIV infection--New York, 2012-2015. MMWR Morb Mortal Wkly Rep. 2015;64(46):1296\u2013301.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"367_CR35","doi-asserted-by":"crossref","first-page":"e0178737","DOI":"10.1371\/journal.pone.0178737","volume":"12","author":"RR Patel","year":"2017","unstructured":"Patel RR, Mena L, Nunn A, et al. Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention. PLoS One. 2017;12(5):e0178737.","journal-title":"PLoS One"},{"key":"367_CR36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1471-2334-13-217","volume":"13","author":"V Puro","year":"2013","unstructured":"Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G. Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists. BMC Infect Dis. 2013;13:217.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"367_CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.amepre.2016.07.031","volume":"52","author":"JR Raifman","year":"2017","unstructured":"Raifman JR, Flynn C, German D. Healthcare provider contact and pre-exposure prophylaxis in Baltimore men who have sex with men. Am J Prev Med. 2017;52(1):55\u201363.","journal-title":"Am J Prev Med"},{"issue":"5","key":"367_CR38","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s10461-016-1625-1","volume":"21","author":"AE Petroll","year":"2017","unstructured":"Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256\u201367.","journal-title":"AIDS Behav"},{"issue":"4","key":"367_CR39","first-page":"287","volume":"40","author":"J Sanchez-Rubio Ferrandez","year":"2016","unstructured":"Sanchez-Rubio Ferrandez J, Martinez Sesmero JM, Navarro Aznarez H, Fernandez Espinola S, Escobar Rodriguez I, Ventura Cerda JM. Perceptions about HIV pre-exposure prophylaxis among healthcare professionals in Spain (PERPPRES study). Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2016;40(4):287\u2013301.","journal-title":"Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria"},{"issue":"9","key":"367_CR40","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1089\/aid.2013.0090","volume":"29","author":"H Senn","year":"2013","unstructured":"Senn H, Wilton J, Sharma M, Fowler S, Tan DH. Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations. AIDS Res Hum Retrovir. 2013;29(9):1183\u20139.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"6","key":"367_CR41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1331\/JAPhA.2014.14014","volume":"54","author":"KM Shaeer","year":"2014","unstructured":"Shaeer KM, Sherman EM, Shafiq S, Hardigan P. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis. Journal of the American Pharmacists Association : JAPhA. 2014;54(6):610\u20137.","journal-title":"Journal of the American Pharmacists Association : JAPhA"},{"issue":"Suppl 1","key":"367_CR42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/hiv.12231","volume":"16","author":"S Sharma","year":"2015","unstructured":"Sharma S, Babiker AG, Emery S, et al. Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT strategic timing of AntiRetroviral treatment (START) trial. HIV medicine. 2015;16(Suppl 1):30\u20136.","journal-title":"HIV medicine"},{"issue":"6","key":"367_CR43","doi-asserted-by":"crossref","first-page":"e0156592","DOI":"10.1371\/journal.pone.0156592","volume":"11","author":"DK Smith","year":"2016","unstructured":"Smith DK, Mendoza MC, Stryker JE, Rose CE. PrEP awareness and attitudes in a National Survey of primary care clinicians in the United States, 2009-2015. PLoS One. 2016;11(6):e0156592.","journal-title":"PLoS One"},{"issue":"5","key":"367_CR44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1089\/aid.2013.0212","volume":"30","author":"EC Tang","year":"2014","unstructured":"Tang EC, Sobieszczyk ME, Shu E, Gonzales P, Sanchez J, Lama JR. Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in lima, Peru. AIDS Res Hum Retrovir. 2014;30(5):416\u201324.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"10","key":"367_CR45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/apc.2013.0173","volume":"27","author":"D Tellalian","year":"2013","unstructured":"Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDs. 2013;27(10):553\u20139.","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"367_CR46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/SMJ.0b013e31824f1a1b","volume":"105","author":"A Tripathi","year":"2012","unstructured":"Tripathi A, Ogbuanu C, Monger M, Gibson JJ, Duffus WA. Preexposure prophylaxis for HIV infection: healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern US. South Med J. 2012;105(4):199\u2013206.","journal-title":"South Med J"},{"issue":"5","key":"367_CR47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.japh.2016.05.004","volume":"56","author":"EJ Unni","year":"2016","unstructured":"Unni EJ, Lian N, Kuykendall W. Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a mountain west state. Journal of the American Pharmacists Association : JAPhA. 2016;56(5):527\u201332. e1","journal-title":"Journal of the American Pharmacists Association : JAPhA"},{"issue":"7","key":"367_CR48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/apc.2012.0030","volume":"26","author":"JM White","year":"2012","unstructured":"White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDs. 2012;26(7):395\u2013405.","journal-title":"AIDS Patient Care STDs"},{"issue":"8","key":"367_CR49","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0956462415589896","volume":"27","author":"D Yoong","year":"2016","unstructured":"Yoong D, Naccarato M, Sharma M, Wilton J, Senn H, Tan DH. Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis. Int J STD AIDS. 2016;27(8):608\u201316.","journal-title":"Int J STD AIDS"},{"issue":"7","key":"367_CR50","doi-asserted-by":"crossref","first-page":"e40603","DOI":"10.1371\/journal.pone.0040603","volume":"7","author":"EA Arnold","year":"2012","unstructured":"Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One. 2012;7(7):e40603.","journal-title":"PLoS One"},{"issue":"6","key":"367_CR51","doi-asserted-by":"crossref","first-page":"e0157324","DOI":"10.1371\/journal.pone.0157324","volume":"11","author":"SK Calabrese","year":"2016","unstructured":"Calabrese SK, Magnus M, Mayer KH, et al. Putting PrEP into practice: lessons learned from early-adopting U.S. Providers' firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS One. 2016;11(6):e0157324.","journal-title":"PLoS One"},{"issue":"4","key":"367_CR52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1089\/apc.2017.0002","volume":"31","author":"SK Calabrese","year":"2017","unstructured":"Calabrese SK, Magnus M, Mayer KH, et al. \"support your client at the space that They're in\": HIV pre-exposure prophylaxis (PrEP) Prescribers' perspectives on PrEP-related risk compensation. AIDS Patient Care STDs. 2017;31(4):196\u2013204.","journal-title":"AIDS Patient Care STDs"},{"issue":"9","key":"367_CR53","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s10461-014-0839-3","volume":"18","author":"D Krakower","year":"2014","unstructured":"Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18(9):1712\u201321.","journal-title":"AIDS Behav"},{"issue":"3","key":"367_CR54","doi-asserted-by":"crossref","first-page":"e0152361","DOI":"10.1371\/journal.pone.0152361","volume":"11","author":"O Martinez","year":"2016","unstructured":"Martinez O, Wu E, Levine EC, et al. Integration of social, cultural, and biomedical strategies into an existing couple-based behavioral HIV\/STI prevention intervention: voices of Latino male couples. PLoS One. 2016;11(3):e0152361.","journal-title":"PLoS One"},{"issue":"4","key":"367_CR55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/apc.2014.0273","volume":"29","author":"TL Mullins","year":"2015","unstructured":"Mullins TL, Lally M, Zimet G, Kahn JA. Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents. AIDS Patient Care STDs. 2015;29(4):193\u2013203.","journal-title":"AIDS Patient Care STDs"},{"key":"367_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-597X-10-1","volume":"10","author":"AY Spector","year":"2015","unstructured":"Spector AY, Remien RH, Tross S. PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives. Substance abuse treatment, prevention, and policy. 2015;10:1.","journal-title":"Substance abuse treatment, prevention, and policy"},{"key":"367_CR57","doi-asserted-by":"crossref","unstructured":"Wheelock A, Eisingerich AB, Gomez GB, Gray E, Dybul MR, Piot P. Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study. BMJ Open 2012;2(4).","DOI":"10.1136\/bmjopen-2012-001234"},{"issue":"4 Suppl 3","key":"367_CR58","doi-asserted-by":"crossref","first-page":"19949","DOI":"10.7448\/IAS.18.4.19949","volume":"18","author":"CF Caceres","year":"2015","unstructured":"Caceres CF, Koechlin F, Goicochea P, et al. The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention. J Int AIDS Soc. 2015;18(4 Suppl 3):19949.","journal-title":"J Int AIDS Soc"},{"issue":"4 Suppl 3","key":"367_CR59","doi-asserted-by":"crossref","first-page":"19973","DOI":"10.7448\/IAS.18.4.19973","volume":"18","author":"C Hankins","year":"2015","unstructured":"Hankins C, Macklin R, Warren M. Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access. J Int AIDS Soc. 2015;18(4 Suppl 3):19973.","journal-title":"J Int AIDS Soc"},{"issue":"7(Suppl 6)","key":"367_CR60","doi-asserted-by":"crossref","first-page":"21107","DOI":"10.7448\/IAS.19.7.21107","volume":"19","author":"S Hosek","year":"2016","unstructured":"Hosek S, Celum C, Wilson CM, Kapogiannis B, Delany-Moretlwe S, Bekker LG. Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa. J Int AIDS Soc. 2016;19(7(Suppl 6)):21107.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"367_CR61","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10461-016-1627-z","volume":"21","author":"FM Koechlin","year":"2017","unstructured":"Koechlin FM, Fonner VA, Dalglish SL, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325\u201335.","journal-title":"AIDS Behav"},{"issue":"6","key":"367_CR62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/COH.0b013e3283590446","volume":"7","author":"D Krakower","year":"2012","unstructured":"Krakower D, Mayer KH. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012;7(6):593\u20139.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"367_CR63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/COH.0000000000000206","volume":"11","author":"DS Krakower","year":"2016","unstructured":"Krakower DS, Mayer KH. The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS. 2016;11(1):41\u20138.","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"367_CR64","first-page":"85","volume":"23","author":"RJ Landovitz","year":"2015","unstructured":"Landovitz RJ. Preexposure prophylaxis for HIV prevention: what we know and what we still need to know for implementation. Topics in antiviral medicine. 2015;23(2):85\u201390.","journal-title":"Topics in antiviral medicine"},{"issue":"12","key":"367_CR65","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1080\/21645515.2016.1231258","volume":"12","author":"JM McNicholl","year":"2016","unstructured":"McNicholl JM. Combining biomedical preventions for HIV: vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions. Human vaccines & immunotherapeutics. 2016;12(12):3202\u201311.","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"1","key":"367_CR66","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/QCO.0000000000000340","volume":"30","author":"D Nugent","year":"2017","unstructured":"Nugent D, Gilson R. Where next with preexposure prophylaxis? Curr Opin Infect Dis. 2017;30(1):44\u20139.","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"367_CR67","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11904-016-0308-x","volume":"13","author":"JL Marcus","year":"2016","unstructured":"Marcus JL, Volk JE, Pinder J, et al. Successful implementation of HIV Preexposure prophylaxis: lessons learned from three clinical settings. Current HIV\/AIDS reports. 2016;13(2):116\u201324.","journal-title":"Current HIV\/AIDS reports"},{"issue":"6","key":"367_CR68","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11096-012-9709-0","volume":"34","author":"C Bruno","year":"2012","unstructured":"Bruno C, Saberi P. Pharmacists as providers of HIV pre-exposure prophylaxis. Int J Clin Pharm. 2012;34(6):803\u20136.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"367_CR69","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/COH.0000000000000223","volume":"11","author":"G Cairns","year":"2016","unstructured":"Cairns G, McCormack S, Molina JM. The European preexposure prophylaxis revolution. Curr Opin HIV AIDS. 2016;11(1):74\u20139.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"367_CR70","first-page":"11","volume":"7","author":"KA Clauson","year":"2009","unstructured":"Clauson KA, Polen HH, Joseph SA, Zapantis A. Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention. Pharm Pract. 2009;7(1):11\u20138.","journal-title":"Pharm Pract"},{"issue":"1","key":"367_CR71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3122\/jabfm.2016.01.150223","volume":"29","author":"J Conniff","year":"2016","unstructured":"Conniff J, Evensen A. Preexposure prophylaxis (PrEP) for HIV prevention: the primary care perspective. Journal of the American Board of Family Medicine : JABFM. 2016;29(1):143\u201351.","journal-title":"Journal of the American Board of Family Medicine : JABFM"},{"issue":"1","key":"367_CR72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/COH.0000000000000222","volume":"11","author":"R Elion","year":"2016","unstructured":"Elion R, Coleman M. The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA. Curr Opin HIV AIDS. 2016;11(1):67\u201373.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"367_CR73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0897190014562351","volume":"28","author":"KW Ferrell","year":"2015","unstructured":"Ferrell KW, Woodard LM, Woodard TJ. Role of medication therapy management in preexposure prophylaxis therapy for HIV prevention. J Pharm Pract. 2015;28(1):10\u20132.","journal-title":"J Pharm Pract"},{"issue":"4","key":"367_CR74","doi-asserted-by":"crossref","first-page":"ofv126","DOI":"10.1093\/ofid\/ofv126","volume":"2","author":"RM Grant","year":"2015","unstructured":"Grant RM, Smith DK. Integrating antiretroviral strategies for human immunodeficiency virus prevention: post- and pre-exposure prophylaxis and early treatment. Open forum infectious diseases. 2015;2(4):ofv126.","journal-title":"Open forum infectious diseases"},{"issue":"1","key":"367_CR75","doi-asserted-by":"crossref","first-page":"21263","DOI":"10.7448\/IAS.19.1.21263","volume":"19","author":"T Horn","year":"2016","unstructured":"Horn T, Sherwood J, Remien RH, Nash D, Auerbach JD. Towards an integrated primary and secondary HIV prevention continuum for the United States: a cyclical process model. J Int AIDS Soc. 2016;19(1):21263.","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"367_CR76","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/cid\/civ664","volume":"61","author":"CF Kelley","year":"2015","unstructured":"Kelley CF, Kahle E, Siegler A, et al. Applying a PrEP continuum of care for men who Have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590\u20137.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"367_CR77","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/dewb.12029","volume":"13","author":"NJ Kenworthy","year":"2013","unstructured":"Kenworthy NJ, Bulled N. From modeling to morals: imagining the future of HIV PREP in Lesotho. Developing world bioethics. 2013;13(2):70\u20138.","journal-title":"Developing world bioethics"},{"issue":"6","key":"367_CR78","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.eimc.2016.11.016","volume":"35","author":"S Moreno","year":"2017","unstructured":"Moreno S, Antela A, Garcia F, et al. Executive summary: pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016. Enfermedades infecciosas y microbiologia clinica. 2017;35(6):377\u201383.","journal-title":"Enfermedades infecciosas y microbiologia clinica"},{"issue":"51","key":"367_CR79","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7748\/ns.30.51.30.s30","volume":"30","author":"L Porter","year":"2016","unstructured":"Porter L. Help end the HIV epidemic. Nursing standard (Royal College of Nursing (Great Britain) : 1987). 2016;30(51):30.","journal-title":"Nursing standard (Royal College of Nursing (Great Britain) : 1987)"},{"issue":"3","key":"367_CR80","first-page":"219","volume":"40","author":"J Sanchez-Rubio Ferrandez","year":"2016","unstructured":"Sanchez-Rubio Ferrandez J, Martinez Sesmero JM. Pre-exposure prophylaxis for the prevention of HIV infection: a new prevention paradigm? Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2016;40(3):219\u201324.","journal-title":"Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria"},{"issue":"2","key":"367_CR81","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/QAI.0000000000001354","volume":"75","author":"P Kasaie","year":"2017","unstructured":"Kasaie P, Pennington J, Shah MS, et al. The impact of preexposure prophylaxis among men who have sex with men: an individual-based model. J Acquir Immune Defic Syndr. 2017;75(2):175\u201383.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"18","key":"367_CR82","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1097\/QAD.0000000000000460","volume":"28","author":"J Kessler","year":"2014","unstructured":"Kessler J, Myers JE, Nucifora KA, et al. Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York. AIDS. 2014;28(18):2683\u201391.","journal-title":"AIDS"},{"issue":"27","key":"367_CR83","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. NEnglJMed. 2010;363(27):2587\u201399.","journal-title":"NEnglJMed"},{"issue":"23","key":"367_CR84","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"JM Molina","year":"2015","unstructured":"Molina JM, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237\u201346.","journal-title":"N Engl J Med"},{"issue":"10013","key":"367_CR85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53\u201360.","journal-title":"Lancet"},{"issue":"3","key":"367_CR86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033119","volume":"7","author":"DS Krakower","year":"2012","unstructured":"Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoSOne. 2012;7(3):e33119.","journal-title":"PLoSOne"},{"key":"367_CR87","unstructured":"Centers for Disease Control and Prevention (CDC). Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR. 60(3):65\u20138."},{"issue":"46","key":"367_CR88","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.15585\/mmwr.mm6446a4","volume":"64","author":"DK Smith","year":"2015","unstructured":"Smith DK, Van Handel M, Wolitski RJ, et al. Vital signs: estimated percentages and numbers of adults with indications for Preexposure prophylaxis to prevent HIV acquisition--United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(46):1291\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"367_CR89","unstructured":"Molina JM. PrEP rollout in France. International AIDS Conference in Durban, 17\u201322 July 2016. Oral abstract WEWS0804. Available at: http:\/\/programme.aids2016.org\/ Last accessed on 2 July 2016."},{"key":"367_CR90","unstructured":"NHS England. NHS England announces major extension of national HIV prevention programme with Public Health England and funding for ten new specialised treatments. Special comissioning. 4 December 2016. Availalbe online at https:\/\/www.england.nhs.uk\/2016\/12\/hiv-prevention-pregramme\/ . Last accessed 20 June 2017."},{"key":"367_CR91","doi-asserted-by":"crossref","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: WHO; 2015. 6. Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on Implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS ONE. 2012;7(7):e40603.","DOI":"10.1371\/journal.pone.0040603"},{"key":"367_CR92","unstructured":"Zablotska I. Expanded PrEP implementation in communities in NSW, Australia (EPIC-NSW): evidence-based implementation study. International AIDS Conference in Durban, 17\u201322 July 2016. Oral abstract FRAE0105. Available at: http:\/\/programme.aids2016.org\/ Last accessed on 2 July 2016."},{"issue":"5","key":"367_CR93","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2352-3018(16)30020-0","volume":"3","author":"The Lancet H","year":"2016","unstructured":"The Lancet H. NHS England should reconsider PrEP decision. Lancet Hiv. 2016;3(5):e191.","journal-title":"Lancet Hiv"},{"key":"367_CR94","doi-asserted-by":"crossref","unstructured":"UK PrEP decision re-ignites HIV activism. Lancet 2016; 387(10027):1484.","DOI":"10.1016\/S0140-6736(16)30186-6"},{"key":"367_CR95","unstructured":"Australian Federation of AIDS Organisations (AFAO). We can end HIV by 2020. URL: http:\/\/endinghiv.org.au \/ Last accessed 10 February 2016."},{"issue":"1","key":"367_CR96","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1014528612685","volume":"6","author":"D Heckathorn","year":"2002","unstructured":"Heckathorn D, Semaan S, Broadhead R, Hughes J. Extensions of respondent-driven sampling: a new approach to the study of injecting drug users aged 18-25. AIDS Behav. 2002;6(1):55\u201367.","journal-title":"AIDS Behav"},{"issue":"1","key":"367_CR97","first-page":"58","volume":"38","author":"MH Katz","year":"2000","unstructured":"Katz MH, Cunningham WE, Mor V, et al. Prevalence and predictors of unmet need for supportive services among HIV-infected persons: impact of case management. MedCare. 2000;38(1):58\u201369.","journal-title":"MedCare"},{"issue":"2","key":"367_CR98","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S2055-6640(20)30291-0","volume":"3","author":"TA Crowell","year":"2017","unstructured":"Crowell TA, Lyall H, Malatinkova E, et al. Highlights from the 24th conference on retroviruses and opportunistic infections: 13-16 February 2017, Seattle, Washington, USA. Journal of virus eradication. 2017;3(2):101\u20138.","journal-title":"Journal of virus eradication"},{"key":"367_CR99","unstructured":"NSW Government. NSW health Telehealth framework and implementation strategy 2016\u20132021. Available online at: http:\/\/www.health.nsw.gov.au\/telehealth\/Publications\/NSW-telehealth-framework.pdf . Last accessed on 18 May 2017."},{"issue":"1","key":"367_CR100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/COH.0000000000000217","volume":"11","author":"V Cambiano","year":"2016","unstructured":"Cambiano V, Miners A, Phillips A. What do we know about the cost-effectiveness of HIV preexposure prophylaxis, and is it affordable? Curr Opin HIV AIDS. 2016;11(1):56\u201366.","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-017-0367-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-017-0367-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-017-0367-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T12:09:20Z","timestamp":1603195760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-017-0367-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["367"],"URL":"https:\/\/doi.org\/10.1007\/s11904-017-0367-7","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]}}}